2024 Rome, Italy

C-02 Wendy Chu
Optimizing dosing strategies for post-kala-azar dermal leishmaniasis: a geographical comparison of systemic and skin pharmacokinetics and pharmacodynamics of antileishmanial drugs
Thursday 8:30-8:55
C-03 Selma El Messaoudi
Mechanistic modeling of the long-term dynamics of viral markers to predict the outcome of combination therapy in chronic HBV and HDV infections
Thursday 8:55-9:20
C-04 Julie Dudasova
Logistic regression-based approach to assess heterogeneity in vaccine efficacy using immunogenicity measurements in phase 3 clinical trials
Thursday 9:20-9:45